Fomivirsen approved for CMV retinitis: first antisense drug.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D013873:Thionucleotides / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D013873:Thionucleotides; C091346:fomivirsen